CDC Health Advisory - Increase in Extensively Drug-Resistant Shigellosis in the United States

Published: 02/24/2023

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Clinical Lab,
  • Pharmacy,
  • Rural Health Clinics

The Centers for Disease Control and Prevention (CDC) has been monitoring an increase in extensively drug-resistant (XDR) Shigella infections (shigellosis) reported through national surveillance systems. According to the CDC, in 2022 approximately 5% of Shigella infections reported to CDC were caused by XDR strains, compared with 0% in 2015. Clinicians treating patients infected with XDR strains have limited antimicrobial treatment options. 

Shigella bacteria are easily transmissible. XDR Shig…

Sign Up for Free Trial